NCT07273201 Isolated Versus Synergetic Muscle Facilitation on Upper Limb Functional Performance in Acute Stroke
| NCT ID | NCT07273201 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Acute Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-10-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomized controlled clinical trial that will be carried out to investigate the effect of isolated versus synergetic muscle facilitation on upper limb functional performance in patients with acute stroke. RESEARCH QUESTION: Is there a difference between isolated and synergetic muscle facilitation on upper limb functional performance in patients with acute stroke? It will be hypothesized that: There will be no difference between isolated and synergetic muscle facilitation on upper limb task-oriented training in patients with acute stroke. Treatment procedures: Study group (A): patients will receive a physical therapy program in the form of a range of motion exercise, electrical muscle stimulation, stretching exercise, mental practice with motor imagery, and isolated muscle facilitation using electromyography (EMG) biofeedback for six weeks and followed by task-oriented training of the upper limb for six weeks control group (B): will receive a standard physical therapy program including range of motion exercise, electrical muscle stimulation, Mental practice with motor imagery and stretching exercise, synergetic muscle facilitation for six weeks, and followed by task-oriented training of the upper limb for six weeks.
Eligibility Criteria
Inclusion Criteria: * Unilateral Middle cerebral artery (MCA) stroke patients * Brunnstrom stage of recovery 1\& 2 * Normal body mass index (18.5 - 24.99 kg/m2) * Dominant handedness Exclusion Criteria: * Perceptual, apraxia, major cognitive deficits * Recurrent stroke * Subjects with cerebellar lesions, painful or subluxated shoulder, any contracture or deformity of the upper extremity
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07273201 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 60 Years, studying Acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07273201 currently recruiting?
Yes, NCT07273201 is actively recruiting participants. Contact the research team at Mohamed.Mousa@pt.cu.edu.eg for enrollment information.
Where is the NCT07273201 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07273201 clinical trial?
NCT07273201 is sponsored by Cairo University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.